Cargando…
Seasonality of Respiratory Syncytial Virus — United States, 2017–2023
Autores principales: | Hamid, Sarah, Winn, Amber, Parikh, Rishika, Jones, Jefferson M., McMorrow, Meredith, Prill, Mila M., Silk, Benjamin J., Scobie, Heather M., Hall, Aron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078848/ https://www.ncbi.nlm.nih.gov/pubmed/37022977 http://dx.doi.org/10.15585/mmwr.mm7214a1 |
Ejemplares similares
-
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Jones, Jefferson M., et al.
Publicado: (2023) -
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2023) -
Respiratory syncytial virus‐associated deaths in the United States according to death certificate data, 2005 to 2016
por: Prill, Mila M., et al.
Publicado: (2021) -
Respiratory Syncytial Virus Activity — United States, July 2011–January 2013
por: Haynes, Amber K., et al.
Publicado: (2013) -
Respiratory Syncytial Virus — United States, July 2012–June 2014
por: Haynes, Amber K., et al.
Publicado: (2014)